WASHINGTON, Aug. 13, 2018 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it
has named Timothy Williams as
Vanda's Senior Vice President, General Counsel and Secretary.
"I am very pleased to welcome Tim to the Vanda executive
management team," said Mihael H.
Polymeropoulos, M.D., President and CEO of Vanda. "He is an
exceptional leader and lawyer and brings a wealth of experience
that we expect will prove instrumental as we continue to execute
our global strategy."
Prior to joining Vanda, Mr. Williams served as Executive Vice
President, General Counsel, Chief Compliance Officer and Corporate
Secretary at AgNovos Healthcare, a medical device company focused
on bone health. Prior to this position, Mr. Williams was Senior
Legal Counsel and Assistant Secretary at Stryker Corporation, a
global medical technology company, where he led the legal
department's global M&A, corporate governance, and securities
groups.
Before joining Stryker, Mr. Williams practiced law in
Chicago at Mayer Brown LLP and
Bryan Cave LLP. Mr. Williams received his Bachelor of Music and
Masters of Music from Western Michigan
University and his Juris Doctor from the University of Michigan.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Corporate Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-the-appointment-of-general-counsel-300696199.html
SOURCE Vanda Pharmaceuticals Inc.